Osaic Holdings
NRIX icon

Osaic Holdings’s Nurix Therapeutics NRIX Stock Holding History

Osaic Holdings’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
10,500
+8,572
+445% +$146K ﹤0.01% 4230
2026
Q1 		$29.9K Sell
1,928
-76
-4% -$1.26K ﹤0.01% 5585
2025
Q4 		$38K Buy
2,004
+270
+16% +$3.88K ﹤0.01% 5427
2025
Q3 		$16K Sell
1,734
-8
-0.5% -$83 ﹤0.01% 6081
2025
Q2 		$19.8K Buy
1,742
+467
+37% +$5.05K ﹤0.01% 5715
2025
Q1 		$15.1K Buy
1,275
+462
+57% +$7.73K ﹤0.01% 5543
2024
Q4 		$15.3K Sell
813
-484
-37% -$11.1K ﹤0.01% 5519
2024
Q3 		$29.1K Buy
1,297
+14
+1% +$317 ﹤0.01% 5125
2024
Q2 		$26.8K Buy
+1,283
New +$20K ﹤0.01% 5139
2022
Q4 		– Sell
-1,000
Closed -$13K – 7357
2022
Q3 		$13K Buy
+1,000
New +$15.8K ﹤0.01% 5872

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's NRIX Position: Q2 2026 in Review

Osaic Holdings increased its Nurix Therapeutics (NRIX) stake by 445% in Q2 2026, buying an estimated $146K and bringing the position to 10,500 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #4230.

Osaic Holdings first reported a position in NRIX in Q3 2022 and has held it in 10 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Osaic Holdings held 10,500 shares of Nurix Therapeutics worth $255K as of Q2 2026.
  • Osaic Holdings bought 8,572 Nurix Therapeutics shares in Q2 2026, an estimated $146K.
  • Nurix Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4230 holding.
  • Osaic Holdings first reported a position in Nurix Therapeutics in Q3 2022 and has held it in 10 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.